Large Tumor Size is an Indicator for the Timely Administration of Adjuvant Radiotherapy in Luminal Breast Cancer with Positive Lymph Node

PURPOSE: The optimum timing of adjuvant radiotherapy for breast cancer patients who had undergone surgery remains unclear. The present study aimed to identify the clinical factors which could assist the selecting of time interval (TI) between surgery and adjuvant radiotherapy in luminal breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Kai-Yun, Zou, Wei-Liang, Ding, Lin, Bi, Zhuo-Fei, Yao, He-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884945/
https://www.ncbi.nlm.nih.gov/pubmed/33603478
http://dx.doi.org/10.2147/CMAR.S293470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884945/
https://www.ncbi.nlm.nih.gov/pubmed/33603478
http://dx.doi.org/10.2147/CMAR.S293470

Ejemplares similares